Related Experiment Video

Updated: Jun 25, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

High ratio of Duffy (a+b+) phenotype in patients with multiple myeloma compared to healthy controls

Nil Guler, Mehmet Turgut, Duzgun Ozatli

    Hematological Oncology
    |February 12, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
    07:53

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

    Published on: April 15, 2022

    Related Experiment Videos

    Last Updated: Jun 25, 2026

    Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
    10:41

    Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

    Published on: March 29, 2017

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
    07:53

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

    Published on: April 15, 2022

    Related Concept Videos

    Lethal Alleles02:41

    Lethal Alleles

    Agouti: A Lethal Allele
    Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
    Multiple Allele Traits01:49

    Multiple Allele Traits

    The Concept of Multiple Allelism

    Articles linked to this work by shared authors, journal, and citation graph.

    Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Assessing Artificial Intelligence Language Models for Patient-Oriented Information on Chiari Malformation Types: A Structured Multinational Evaluation Based on Real-World Expectations.

    World neurosurgery·2026

    FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye.

    PloS one·2026

    Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

    Journal of clinical medicine·2026

    Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

    HemaSphere·2026

    Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

    The New England journal of medicine·2026

    NUDT21 Promotes Myelodysplastic Syndrome Progression by Regulating SRSF2 Expression via Alternative Polyadenylation.

    Hematological oncology·2026

    Clinical Impact of CTLA4 and LAG3 Single-Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T-Cell Therapy.

    Hematological oncology·2026

    Clinicopathologic Features and Survival Determinants of Hepatosplenic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

    Hematological oncology·2026

    Host Fitness: A Missing Dimension of Precision Medicine in Older Acute Myeloid Leukemia.

    Hematological oncology·2026

    Venetoclax-Based Regimens in Newly Diagnosed FLT3-Mutated Older or Unfit Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Comparative and Single-Arm Outcomes.

    Hematological oncology·2026

    Impact of Residual Disease Localization Before Allogeneic Hematopoietic Stem Cell Transplantation on Outcomes in Adult T-Cell Leukemia-Lymphoma.

    Hematological oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us